To develop 1 H MR spectroscopy that provides distinction of g-aminobutyric acid (GABA) signal at 3 T in vivo.
signals are strongly obscured by the large singlets of Nacetylaspartate (NAA) and total creatine (tCr), whereas the C2-proton resonance at 2.29 ppm is extensively overlapped with the abundant Glu C4-proton resonance (2.35 ppm).
The signal overlap is usually overcome by means of some form of spectral editing that uses the J-coupling evolution of the GABA spin system. One example is J-difference editing (MEGA), in which the GABA 3.01-ppm resonance is difference-edited using its coupling to the 1.89 ppm resonance. This editing has several limitations. First, the macromolecule (MM) species that has J-coupled resonances at approximately 3.0 and 1.7 ppm can be partially coedited and interfere with GABA measurement. The co-edited signal of the MM species (bound lysine) that has short T 2 diminishes rapidly, 4, 5 but mobile lysine, whose T 2 may be as long as metabolite T 2 , 6 can bring about a co-edited signal at 3.01 ppm as large as the edited GABA signal, even when the editing 180 8 RF pulse is highly selective (e.g., 26-ms-long delay alternating with nutation for tailored excitation). 7 Although the co-editing of mobile lysine can be effectively minimized by means of symmetric excitation when the editing sequence can house a highly selective long editing RF pulse, 8 mitigation of lysine co-editing is not straightforward in a widely used form of MEGA at 3 T, 9 in which 2 editing 180 8 RF pulses are inserted within a PRESS sequence with TE of 68 to 80 ms. 10 Second, homocarnosine (HC) is coedited in editing of GABA 3.01 ppm resonance, which occurs as a result of the close proximity of the C4-proton and C3-proton resonances of the HC GABA moiety to those of free GABA. 3 Given that the HC level was measured to be approximately 50% of the free GABA level in the human brain biopsies, 11 contamination of the HC GABA moiety signal is very concerning, because HC is entirely co-edited in GABA editing. Third, complete cancelation of the tCr CH 3 singlet cannot be taken for granted in vivo. For GABA and tCr concentrations of 1 and 8 mM respectively, for which the unedited GABA to tCr CH 3 signal ratio is only approximately 4%, the MEGA-edited GABA signal at 3.01 ppm may be always smaller than 2% of the unedited tCr CH 3 signal because of the chemical-shift-displacement effects. Given the prevalence of frequency drifts caused by subject motions and potential instability of shimming currents, the spectral location and lineshape of the tCr CH 3 singlet could be varied during the relatively long GABA MRS scans. Acceptable suppression of the tCr signal (e.g., suppression ratio of 500 for residual tCr signal as small as 10% of the edited GABA signal) may be achievable only by rigorous retrospective data processing following data acquisitions with cardiac triggering. 12 Finally, frequency drifts may incur variations in the rotation angle of the GABA 1.89-ppm spins and consequently the difference-edited GABA signal strength with time during the scan, which can lead to erroneous estimation of GABA. The frequency drift artifacts can be mitigated using editing 180 8 RF pulses with large bandwidth, but use of these pulses will increase MM co-editing. Taken together, measurement of GABA using MEGA, which is widely used at 3T, is prone to several types of measurement errors and thus may not be ideally suitable for studying brain diseases in which alterations in GABA level are moderate, suggesting development of an alternative, robust MRS technique without considerable complications in data processing and signal contamination at 3 T, a field strength that is widely used in clinical studies. Given the presence of complexities with detection of the GABA 3.01 ppm resonance, one may consider detection of the GABA C2-proton resonance (2.29 ppm) for measuring GABA as an alternative. The Glu C4-proton resonance at 2.35 ppm, which is a major obstacle, is relatively distant from the GABA 2.29 ppm resonance. The Glu C4 protons are strongly coupled to the C3 protons, whereas the GABA C2 protons are weakly coupled to the C3 protons at 3 T. The signal intensity and pattern of the Glu 2.35 ppm resonance are therefore much more sensitive to the MRS sequence parameters such as inter-RF pulse time delays, compared with the GABA 2.29 ppm resonance. In the case of stimulated-echo acquisition mode with optimized echo and mixing times (168 ms and 28 ms, respectively), 13 the singlequantum coherence evolution during the TE periods, together with the zero-quantum filtering effects of the sequence, can lead to drastic reduction of the Glu C4-proton multiplet, thereby making a GABA signal discernible on the shoulder of the suppressed Glu signal. One more example of the J evolution difference between Glu and GABA is optimized-TE PRESS at 7 T, 14 in which a PRESS TE of 92 ms (TE 1 5 31 ms and TE 2 5 61 ms) gave rise to narrowing of the Glu and GABA multiplets between 2.2 and 2.4 ppm, and thus the GABA and Glu signals were completely discriminated without considerable suppression of the signals, thereby making it possible to codetect GABA and Glu with precision. The significance of these two prior studies is that the GABA estimation may not contain considerable contaminations from lysine and HC, because the lysine resonances are all far from 2.29 ppm, 15 and the C2-proton resonance of the HC GABA moiety is relatively distant (0.1 ppm) from the GABA C2-proton resonance. 16 In addition, direct measurement of the target signal of GABA without need of subtraction between spectra is a great plus. Although a PRESS sequence can offer excellent separation between the GABA and Glu signals at 7 T, 14 which is caused by the effects of the sub-TE optimization on top of the enhanced spectral resolution of J-coupled resonances at the high field, it is unlikely that at 3 T, distinction of the GABA 2.29 ppm signal from the Glu 2.35 ppm signal without sacrificing the Glu signal strength is straightforward by tailoring the PRESS sub-TEs. A triple-refocusing sequence (90 8 -180 8 -180 8 -180 8) has additional inter-RF pulse time delays and thus provides a platform for amplifying the coherence evolution difference between spin resonances, as shown in our recent studies. 17, 18 In this study, we explore triple refocusing for detection of the GABA 2.29 ppm resonance at 3 T. For given RF envelopes, all possible components of the sequence, which included the 4 inter-RF pulse time delays and the duration and carrier frequency of a non-slice-selective 180 8 RF pulse, were tailored, using density-matrix simulations to achieve acceptable signal separation between the GABA C2-proton and Glu C4-proton resonances without considerable reduction of the signal strengths. Following validation of the GABA-optimized triple refocusing in a phantom solution, we tested the method in healthy subjects. Preliminary data from multiple brain regions, which are known to be implicated in many neuropsychiatric disorders, are presented.
| M ETH ODS
Density-matrix simulations were performed at 3 T to optimize the triple-refocusing sequence parameters for distinction between the GABA and Glu signals between 2.2 and 2.4 ppm. The triple-refocusing sequence, with three 180 8 RF pulses following a 90 8 excitation RF pulse, had 4 inter-RF pulse time delays: s 1 , s 2 , s 3 , and s 4 ( Figure 1A ). The second 180 8 was non-slice-selective (NS180), whereas 3 other RF pulses were slice-selective. Volume localization was obtained with a 9.8-ms 90 8 pulse with bandwidth (BW) of 4.2 kHz at half amplitude and two 13.2-ms 180 8 pulses with BW of 1.3 kHz 19 at an RF field strength (B 1 ) of 13.5 lT.
The time evolution of the density operator was calculated by solving the Liouville-von Neumann equation for the Hamiltonian that included Zeeman, chemical shift, scalar coupling terms, and shaped RF and gradient pulses, using a product operator-based transformation matrix algorithm, as described in a previous study. 20 The spatial resolution of slice selection was set to 1% with respect to the slice thickness, namely, 0.01 5 sample length/number of pixels/slice thickness, where the sample length was 2-fold greater than the slice thicknesses with number of pixels (isochromats) of 200. The carrier frequency of the slice-selective RF pulses was set to 2.5 ppm. The 3D localized spectra of Glu and GABA were numerically calculated for 9 NS180 durations (14 to 30 ms, with 2-ms increments) and for TE ( 4 Hz and use of GABA and Glu T 2 of 180 ms, 21 a sequence parameter set was searched for using the following criteria:
(1) GABA C2-proton peak-to-peak amplitude greater than 95% of the zero-TE GABA C2-proton signal amplitude, (2) Glu C4-proton peak-to-peak amplitude greater than 60% of the zero-TE Glu C4-proton signal amplitude, and (3) small variation of Glu signal between 2.25 and 2.32 ppm. The zero-TE signals of GABA and Glu were obtained by scaling 90 8-acquired calculated signals for the localized volume.
Published chemical shift and J-coupling constants were used for the simulations. 3 The computer simulation was programmed with MATLAB (The MathWorks Inc, Natick, MA). Glutamine (Gln) was not included in the simulation for sequence optimization, because the Gln resonances, which are fairly distant from the GABA C2-proton resonance, may not interfere with GABA measurement.
1
H MR experiments were conducted in a whole-body 3T scanner (Philips Medical Systems, Best, Netherlands) equipped with a whole-body coil for RF transmission and a 32-channel phased-array head coil for reception. In vitro tests of the GABA-optimized triple-refocusing sequence were conducted on an aqueous solution (pH 5 7.4) of GABA (3 mM), Glu (30 mM), and Cr (15 mM). Data were acquired with TR 5 9 s and TE 5 74 ms, from a 2 3 2 3 2 cm 3 voxel at the center of the phantom sphere (6-cm diameter). In addition, in vitro experiments were conducted on a phantom with GABA (3 mM), Glu (30 mM), NAA (30 mM), and glycine (36 mM) for comparison of GABA editing by the triple refocusing and MEGA (TE 5 74 ms for both).
In vivo MR scans were carried out in 6 healthy subjects (3 males and 3 females, age 27 6 5 years). The protocol was approved by the institutional review board of the University of Texas Southwestern Medical Center. Written informed consent was obtained from patients prior to MR scans. Triple-refocused MR spectra were obtained from the medial occipital and left parietal regions from all 6 subjects, of whom 3 subjects had additional MRS acquisitions in medial frontal, left frontal, posterior cingulate, and left hippocampus. The MRS scan parameters included TR 5 2 seconds, TE 5 74 ms, sweep width 5 2.5 kHz, and 1024 sampling points. The number of signal averages ranged from 128 to 512 averages, depending on the voxel size (3.9 to 12.2 mL). The carrier frequencies of the slice-selective RF pulses were set at 2.5 ppm to minimize the chemical shift misregistration of resonances between 1 and 4 ppm, and were real-time adjusted for B 0 drifts in each excitation using a vendorsupplied tool (frequency stabilization). Water suppression was obtained with a vendor-supplied 4-pulse variable flip angle scheme. 22 Triple-refocused unsuppressed water was acquired from each voxel for eddy current compensation and multichannel combination. Unsuppressed water was additionally obtained with short-TE (13 ms) MRS and 20-second TR for quantification of metabolites concentrations. Up to second-order shimming was carried out using a vendorsupplied shimming tool. Proper flip angles of the RF pulses were obtained with MRS voxel-localized B 1 calibration followed by confirming equal strengths of triple-refocused and PRESS water signals at TE 5 74 ms. Three-dimensional sagittal T 1 -weighted images were acquired with 1 3 1 3 1 mm 3 resolution. Following the combination of the 32-channel using a vendor-supplied algorithm, the data were zero-filled to 4096 data points prior to Fourier transformation. Spectral fitting was performed with LCModel software (Version 6.2F), 23 using numerically calculated basis spectra of 17 metabolites, which included GABA, Glu, Gln, NAA, HC, myo-inositol, glycine, taurine, scyllo-inositol, aspartate, phosphoethanolamine, lactate, tCr, N-acetylaspartylglutamate, glycerophosphocholine 1 phosphocholine, glucose, and glutathione. The spectral fitting was performed between 0.5 and 4.0 ppm. The Cramer-Rao lower bound was returned as a percentage SD by the LCModel. The contents of gray matter (GM), white matter (WM), and CSF within the MRS voxels were obtained from segmentation of the T 1 -weighted images using Statistical Parametric Mapping software (SPM5). 24 The metabolite signal estimates from the LCModel were normalized to the short-TE water in GM and WM, and subsequently the metabolite concentrations were calculated by setting the mean tCr estimate of the medial occipital brain at 8 mM, 25, 26 similarly as in our previous study. 14 To obtain the metabolite concentrations in pure GM and WM, the metabolite estimates from the voxels were fitted with a linear function of fractional GM content, f GM 5 GM/(GM1WM). Student's ttest was performed for comparison of metabolite estimates among groups. Data are presented as mean 6 SD. Figure 1A) . A numerical simulation showed that, for these triple-refocusing sequence parameters, the GABA signal at 2.29 ppm was clearly separated from the Glu 2.35 ppm signal when broadened to singlet (Cr) linewidth of 4 Hz (Figure 1B) . The upfield sideband of the Glu multiplet was fairly flat between 2.25 and 2.32 ppm, making the GABA 2.29 ppm signal clearly discernible in the sum spectrum. Figure 2A presents numerically calculated spectra of GABA, Glu, and Cr at a concentration ratio of 1:10:5 for Cr-CH 3 singlet linewidths (FWHM) of 3, 5, and 7 Hz. The spectral resolution of GABA with respect to Glu decreased progressively as FWHM increased. The GABA signal was well distinguishable from Glu for FWHM up to 7 Hz. The optimized triple refocusing was tested in an aqueous solution of GABA, Glu, and Cr at a concentration ratio of 1:10:5 ( Figure  2B ). The signal strength and pattern of the calculated sum spectra were in excellent agreement with the phantom data. The FWHM dependence of GABA resolution agreed well between calculation and experiment. Spectral analysis of the phantom data reproduced the prepared concentration ratio within 2% errors, incorporating phantom T 2 values of the chemical compounds (650, 650, and 1200 ms for GABA, Glu, and Cr-CH 3 , respectively). The GABA-optimized TE 5 74 ms triple refocusing was tested in 6 healthy volunteers. Representative in vivo spectra from medial occipital (MO) and left parietal (LP) brain of a healthy volunteer are shown in Figure 3 , together with the voxel positioning and spectral analysis results. The spectral patterns were well reproduced by the spectral fit between 0.5 and 4.0 ppm. A fairly large signal was clearly discernible at 2.29 ppm in the spectrum from the MO voxel, whereas the spectrum from the LP region showed a relatively small signal at 2.29 ppm. The GABA concentration estimate was higher by approximately 2-fold in MO than in the LP region. The GABA Cramer-Rao lower bound was 8 and 12% for the MO and LP regions, respectively. The Glu signal at 2.35 ppm was also greater in MO than in the LP region. The Glu Cramer-Rao lower bound was 3 to 4% in the spectra. To further validate the GABA detection, spectral fitting was undertaken with and without GABA signal in the basis set. In the fitting with GABA, the in vivo spectrum was well reproduced by the fit, leading to noise-level residuals in the proximity of 2.29 ppm (Residuals-1). When GABA was excluded from the fitting, residuals were clearly discernible at approximately 2.29 ppm (Residuals-2), indicating that the signal at 2.29 ppm was primarily attributed to GABA. In addition, we tested the GABA-optimized triple refocusing in the medial frontal (MF), left frontal (LF), posterior cingulate (PC), and left hippocampus (LH) regions (Figure 4 ). The GABA signal at 2.29 ppm was also readily discernible in spectra from these brain regions. The spectral fittings with and without GABA in the basis set resulted in notable differences in the residuals in the proximity of the GABA at 2.29 ppm resonance.
| RES U LTS
Data were acquired from the MO and LP regions in 6 subjects, of whom 3 had additional scans in the MF, LF, PC, and LH regions. For each brain region, the overall spectral pattern was similar among subjects. The residuals at 2.29 ppm from without-GABA fitting were overall larger in spectra from GM-rich regions than in spectra from WM-rich regions. For the total 24 spectra from the 6 subjects, the mean SNRs of NAA (2.01 ppm) and tCr (3.03 ppm) were 224 6 41 and 147 6 30, whereas the mean FWHMs of NAA and tCr were 4.4 6 0.2 and 4.6 6 0.3 Hz, respectively. Here, SNR was the ratio of peak amplitude with respect to the SD F IGUR E 2 A, Numerically calculated triple-refocusing spectra of GABA, Glu, and Cr are presented for Cr FWHM of 3 to 7 Hz. The concentration ratio GABA:Glu:Cr equals 1:10:5. B, Spectra from an aqueous solution with GABA (3 mM), Glu (30 mM), and Cr (15 mM), obtained using the GABAoptimized triple refocusing, are presented for various Cr FWHM, similarly as in calculated spectra. Each of the calculated and phantom spectra was normalized to its Cr peak amplitude. A vertical line is drawn at 2.29 ppm of the residuals between 0.5 and 1 ppm, and the FWHM was obtained from the LCModel-returned singlets.
For the 6 subjects, the mean fractions of GM, WM, and CSF were estimated to be 0.61 6 0.03, 0.23 6 0.02, and 0.16 6 0.04 for MO, and 0.16 6 0.05, 0.81 6 0.08, and 0.03 6 0.04 for LP, respectively. The fractional GM content (i.e., f GM 5 GM/(GM1WM) was then calculated as 0.73 6 0.02 and 0.14 6 0.02 for the MO and LP voxels, respectively ( Table 1 ). The GABA concentration was significantly higher in MO than in LP (0.80 6 0.06 versus 0.51 6 0.07 mM; p 5 2 3 10
25
). We performed linear regression of these MO and LP GABA estimates with respect to f GM (Figure 5) . The GABA levels in pure GM and pure WM (i.e., yaxis intercepts at f GM 5 1 and 0) were estimated as 0.93 and 0.44 mM, respectively, suggesting that GABA is approximately 2-fold higher in pure GM than in pure WM. Glutamate was well measurable in all data with high precision (Cramer-Rao lower bound 5 3 to 4%), and significantly higher in MO than in LP (9.2 6 0.6 versus 6.4 6 0.4 mM, p < .001), resulting in the pure-GM and pure-WM concentrations at 10.4 and 5.8 mM, respectively. The tCr level in MO was also significantly higher than that of LP (p < .001).
Significant difference in GABA between GM-rich and WM-rich regions was also observed in frontal brain (i.e., 0.87 and 0.46 mM in MF and LF, respectively; p 5 .02) ( Table 1) . For the PC voxel, which showed approximately equal contents of GM and WM (i.e., f GM 5 0.57), the GABA estimate was significantly lower compared with other GMdominant regions ( Figure 5 ). Of note, the GABA level in LH was significantly higher than those in MO (p 5 .008) and MF (p 5 .02), whereas the GM contents of the LH, MF, and MO regions were about the same (f GM 5 0.7 to 0.73). For Glu, the concentration was significantly different between GM-rich and WM-rich regions, similarly as in GABA (Figure 5 ), but its distribution throughout the brain (i.e., multiple brain regions) was somewhat different than GABA; namely, the Glu estimate was not significantly different among MO, LH, MF, and PC ( Table 1 ). The tCr concentrations at the multiple locations was largely governed by the GM and WM contents in the voxels.
Finally, in vitro comparison of MEGA and triple refocusing was performed (TE 5 74 ms for both) ( Figure 6 ). In MEGA, GABA and Glu were edited using an editing 180 8 RF pulse (E180) with large bandwidth (88 Hz; 13-ms Gaussian envelope truncated at 10%), implemented within a PRESS sequence with 6.9-ms slice-selective 180 8 RF pulses (BW 1.3 kHz), whose envelope can be found in a previous paper. 19 Because of the effect of the large E180 bandwidth, the NAA singlet (2.01 ppm) and Glu C3-proton resonances (2.04 and 2.12 ppm) were largely dephased in the E180-ON scan ( Figure 6A ). The edited GABA (3.01 ppm) signal was as small as 23% relative to the co-edited Glu (3.75 ppm) signal for their concentration ratio of 1:10. The GABA and Glu signals were 1.6 and 6.8% with respect to that of glycine, Note: The metabolite concentration was estimated with reference to the mean tCr of the MO region at 8 mM, following normalization of metabolite signal estimates to the GM1WM water signal. Data are mean 6 SD (N 5 6 for MO and LP, and N 5 3 for other brain regions). a Significance of the metabolite level difference from the estimates in the medial occipital region (p .001).
whose concentration was prepared to produce a tCr signal strength in in vivo situations (i.e., GABA:Glu:tCr 5 1:10:8).
LCModel analyses of the MEGA and triple-refocusing data showed good agreement, reproducing the prepared concentration ratio, similarly as in the earlier triple-refocusing in vitro data analysis. 
| D IS C US S I ON A ND C ONCL US I ON
The present study reports a novel triple-refocusing scheme for in vivo measurement of GABA at 3 T. Taking advantage of the high variability of strongly coupled spin signals with respect to changes in the inter-RF pulse time delays as well as the nonselective 180 8 RF pulse duration and carrier frequency, the Glu C4-proton signal was effectively manipulated to accomplish distinction between the GABA 2.29 ppm and Glu 2.35 ppm multiplets, and thereby codetection of GABA and Glu with precision. Of note, the TE of the optimized triple refocusing was not very long (74 ms), and thus the T 2 signal loss was moderate. Using this new GABA MRS, we evaluated regional variation of GABA in medial occipital and left parietal regions in healthy human brain. We further tested the method in other clinically relevant brain regions such as frontal brain, hippocampus, and PC. Frontal brain MRS may be relatively vulnerable to subject motion artifacts; thus, precise measurement of low-concentration metabolites such GABA could be challenging. Measurement of GABA in hippocampus, which is also a big challenge because of the small volume of interest in the temporal region, is especially of high significance, given the implications of hippocampus in neuropsychiatric disorders. Our triple-refocused data that were acquired from these technically challenging brain regions in relatively short time frames showed clearly discernible GABA signals at 2.29 ppm, completely separated from the Glu C4-proton resonance, without complicated data processing. This may be the major accomplishment of the present study. The triple-refocusing optimization was carried out for TE 100 ms to avoid extensive T 2 signal loss of the lowconcentration metabolite GABA. It appears that small variation of the Glu signal between 2.25 and 2.32 ppm can be achieved at many TEs between 70 and 100 ms, making the GABA C2-proton signal discernible with respect to the Glu signal ( Figure 7) . Computer simulations showed that the GABA signal variation in the relatively small TE range (30 ms) was minimal (within 20% with respect to the largest ). Each of the 8-TE sequence parameter sets was chosen for minimum variation of the Glu signal between 2.25 and 2.32 ppm for each of TE 5 70 to 72, 74 to 76, 78 to 80, 82 to 84, 86 to 88, 90 to 92, 94 to 96, and 98 to 100 ms. For each TE, the upper panel shows spectra of GABA1Glu (in red) and Glu (in blue), and the lower panel shows spectra of GABA and Glu and a triple-refocused artificial singlet (2.5 ppm, 4 protons). Signals were broadened to singlet FWHM 5 4 Hz. T 2 relaxation effects were not included in the simulation signal at TE 5 74 ms), because the coherence evolution of weakly coupled spins is governed by TE. In contrast, the case of Glu, whose spins are strongly coupled, was very different. For singlet FWHM of 4 Hz, the Glu signal amplitude was decreased to approximately 60% at TE 86 ms when compared with those at TE 84 ms. Unlike the case of weakly coupled spins, the J evolution of strongly coupled spins is sensitive to many sequence parameters of triple refocusing, which is largely because the J-coupling Hamiltonian of strongly coupled spins has in-plane operator terms (i.e., I x S x and I y S y for J-coupled spins I and S) and these terms do not commute with other Hamiltonians. The Glu signal intensity and pattern can be substantially altered with small changes in inter-RF pulse time delays for an arbitrary constant TE. The Glu signal is also affected by the NS180 duration and carrier frequency. Specifically, the upfield side of the Glu C4-proton multiplet, which is critical for distinction of the GABA 2.29 ppm signal from Glu, was sensitive to the NS180 carrier frequency, whereas the GABA signal was virtually independent of the carrier frequency in the simulation results (Figure 8) .
g-Aminobutyric acid may be reliably measurable with MEGA in a contamination-free situation (as shown in our in vitro tests), but the in vivo performance of MEGA is different as a result of contamination of MM and HC. In MEGA editing of GABA in brain, the C2-proton resonances (3.75 ppm) of Glu, Gln, and GSH are co-edited because of the effect of the edited 180 8 RF pulse (E180) on their C3-proton resonances (2.04 to 2.16 ppm). Because this coediting and MM coediting are all affected by the E180 bandwidth, the MM contamination can be qualitatively assessed by comparing the MEGA-edited 3 ppm signal with the coedited 3.75 ppm signal. Computer simulations indicate that when the E180 bandwidth is 98 Hz (as in our phantom test), the edited GABA to co-edited 3.75 ppm signal ratio may be approximately 20% at maximum for GABA:Glu:Gln:GSH of 1:10:3:1. The signal ratio somewhat increases with decreasing E180 bandwidth, but it may not be larger than 40% even when the E180 bandwidth is as small as 38 Hz (e.g., 30-ms Gaussian envelope truncated at 10%). It follows that, when a MEGA-edited signal at approximately 3 ppm is not much smaller compared with the co-edited 3.75 ppm signal, [27] [28] [29] the edited signal at 3 ppm may contain considerable MM contamination, requiring careful data interpretation.
The in vivo GABA estimates of the present study appear to be overall lower than prior GABA measurements by MEGA editing at 3 T. Many studies measured GABA in the MO brain and reported the estimate with reference to tCr at 8 mM, similarly as in this study. Compared with these previous MEGA studies, our GABA estimate in MO brain (0.8 mM, 12 mL voxels) is notably lower. A recent study, which aimed to find regional differences of GABA at 3 T, reported 2.7 mM of GABA in the MO cortex. 30 Several other 3T studies using MEGA reported MO GABA/tCr of 0.15 to 0.2, 31-33 which corresponds to 1.2 to 1.6 mM when the tCr level is set to 8 mM. Discrepancy between our estimation and previous MEGA GABA measurements at 3 T are also seen in other brain regions. Frontal-brain GABA was measured as 1.4 to 2.1 mM in previous studies at 3 T, 30, 34 which is higher than our estimate (0.87 mM). For PC, our estimate of 0.66 mM in a 7-mL voxel is approximately 50% relative to a previous MEGA study in an 18-mL voxel. 35 For ) of 1 to 4.5 ppm (0.5 ppm increments), together with triple-refocused artificial singlet (2.5 ppm, 4 protons). Other sequence parameters were the same as those of the GABA-optimized triple refocusing (i.e., [s 1 , s 2 , s 3 , s 4 ] 5 [13, 17, 24, 20] ms and NS180 duration 5 14 ms). Signals were broadened to singlet FWHM 5 4 Hz. T 2 relaxation effects were not included in the simulation hippocampus, our GABA estimate from a 3.9-mL voxel is approximately 60% of a MEGA measurement of GABA in a much larger voxel (11.3 mL) with most likely lower GM content. In contrast, our GABA estimates are in acceptable agreement with some previous studies. A 7T MEGA study in occipital cortex reported GABA level as 0.75 mM after removing MM contamination. 36 In a double-quantumfiltered GABA imaging study, 37 in which the MM contamination was relatively small (i.e., < 20% of the edited GABA signal), the GABA/tCr estimate in regions with f GM of approximately 70% (similar to our medial-occipital voxel f GM ) was approximately 0.12. Another GABA doublequantum filtering study reported frontal-brain GABA as 0.8 mM after correction for HC contamination, 16 which is close to the GABA estimate of the current study (0.87 mM). Of note, our GABA estimations in MO and frontal brain are in excellent agreement with 2 previous studies 13, 14 that were focused on detection of the GABA 2.29 ppm resonance using optimized-TE MRS. Taken together, the MEGA-edited signal at approximately 3 ppm may contain signals from other compounds such as MM and HC, and thus likely result in overestimation of GABA, depending on the sequence design. Approaches that are focused on distinction of the GABA 2.29 ppm resonance appear to give relatively consistent estimates of GABA among the methods, which suggests that the methodology may confer a relatively robust tool for evaluating the clinically important, low-concentration metabolite GABA.
Our data indicate the presence of regional variation of GABA in the healthy brain. Although the mean f GM of the hippocampal voxel was similar to those of the voxels in MO and frontal brain, the GABA level in the hippocampus was significantly higher compared with other GM-dominant regions (MO, MF, and PC). This suggests that the regional variability of GABA is not solely dependent on the GM and WM contents. The regional variation in the GABA pool size may be in part the result of distinct functions attributed to the specific brain regions. Medial occipital and frontal regions, which are broadly categorized as cortical subtypes, have different functional roles between them. [38] [39] [40] Consequently, the GABAergic and/or glutamatergic activities may be distinct, and thus may lead to variation in the metabolic pool size. Early studies reported that there are distinct GABAergic interneurons in the hippocampus (21 subtypes) and brain cortex. 41, 42 Similarly, PC, which is cytoarchitectonically characterized as a cortical region, showed significantly lower GABA level compared with the MO and frontal cortical regions. Our PC voxels consisted of approximately equal fractions of GM and WM (f GM 57%), unlike the voxels in MO and frontal brain. The relatively low f GM and differential functional property may incur low GABA level in PC compared with other cortical regions. The GABA levels in the WM dominant regions (left parietal and left frontal) showed lower GABA levels compared with the GM-dominant regions, which may be because WM rich regions consist of nerve fibers that connect neurons, whereas GM-rich regions have neuronal core parts that may be more metabolically active and regulated by the functional properties of the brain regions.
The Glu estimates of the present study are in agreement with many previous studies. 25, 26, 43, 44 The Glu concentration was estimated to be higher by approximately 2-fold in pure GM than in pure WM (10.4 versus 5.8 mM). The Glu level was not significantly different among the MO, medial frontal, and hippocampus regions, unlike GABA. Previous immunohistological studies suggested that excitatory pyramidal neurons account for approximately 85% of all cortical neurons and are relatively homogeneous. 45, 46 Because of the uniform and dominant distribution of excitatory pyramidal neurons, the Glu level may be similar across these GM dominant cortical and hippocampal regions. However, the interneurons, which are primarily GABAergic and consist of 16 to 30% of cortical neurons, display synaptic and physiological variability. [47] [48] [49] The diversity and variability of the GABAergic interneurons across the brain may explain the GABA pool size variations seen in the present study.
In conclusion, we have developed a novel triplerefocusing scheme that provides distinction of the GABA 2.29 ppm resonance from the neighboring Glu signal. With well-preserved Glu signal, the optimized triple refocusing permits precise codetection of GABA and Glu in the human brain at 3 T. Importantly, the method performs well in multiple brain locations, including temporal brain such as the hippocampus. Linear regression of GABA estimates with respect to fractional GM content showed approximately 2-fold higher concentration of GABA in pure GM than in pure WM. With minimal contaminations from other compounds, the proposed triple refocusing may provide an effective tool for detecting potential small alterations in GABA and Glu levels in brain diseases at 3 T, a field strength that is widely used in clinical studies. Further work will be required to determine the sensitivity to alterations in GABA level in patient populations, and to accomplish multivoxel imaging of GABA using the triple refocusing.
